To access the full text documents, please follow this link: http://hdl.handle.net/10230/41655
dc.contributor.author | Ferrer, Marta |
---|---|
dc.contributor.author | Giménez Arnau, Anna Maria |
dc.contributor.author | Saldana, Diego |
dc.contributor.author | Janssens, Nico |
dc.contributor.author | Balp, Maria Magdalena |
dc.contributor.author | Khalil, Sam |
dc.contributor.author | Risson, Valéry |
dc.date | 2018 |
dc.identifier.citation | Ferrer M, Giménez-Arnau A, Saldana D, Janssens N, Balp MM, Khalil S. et al. Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: exploratory analysis. J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1191-1197.e5. DOI: 10.1016/j.jaip.2018.04.003 |
dc.identifier.citation | 2213-2201 |
dc.identifier.citation | http://dx.doi.org/10.1016/j.jaip.2018.04.003 |
dc.identifier.uri | http://hdl.handle.net/10230/41655 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | c)2018 The Authors. Published by Elsevier Inc. on behalf of the American Academyof Allergy, Asthma & Immunology. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) .https://doi.org/10.1016/j.jaip.2018.04.0031191 |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.subject | Urticària -- Tractament |
dc.subject | Chronic spontaneous urticaria |
dc.subject | Chronic urticaria |
dc.subject | LASSO model |
dc.subject | Omalizumab |
dc.subject | Symptom return |
dc.subject | Treatment discontinuation |
dc.subject | Urticaria activity |
dc.title | Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: exploratory analysis |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |